Strata Critical Medical, Inc. Stock Analysis & AI Score
Strata Critical Medical, Inc. (SRTA) has an ST Score of 49.4 (C+), driven by its Financial Strength (A-) and held back by its Momentum (D+). Analysts rate it Buy with a $7.25 price target (+37.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Strata Critical Medical, Inc. (SRTA) has an ST Score of 49.4 (C+), driven by its Financial Strength (A-) and held back by its Momentum (D+). Analysts rate it Buy with a $7.25 price target (+37.6% upside).
- Strongest
- Financial StrengthA-
- Weakest
- MomentumD+
All factor grades
- Financial StrengthA-
- GrowthB
- ForecastB
- ValuationC+
- ProfitabilityC+
- MomentumD+
- Piotroski2/9
Contact
SRTA stock: frequently asked questions
What is SRTA's ST Score?
Strata Critical Medical, Inc. (SRTA) has an ST Score of 49.4 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SRTA a buy, hold, or sell?
Analysts rate SRTA a Buy, with a price target of $7.25 (+37.6% vs the current price). Our ST Score grades it C+ (49.4/100). The ST Score is a data-driven signal, not a recommendation.
What are SRTA's factor grades?
Valuation C+, Profitability C+, Financial Strength A-, Momentum D+, Growth B, Forecast B.
What is SRTA's valuation grade?
Strata Critical Medical, Inc. (SRTA) earns a valuation grade of C+, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SRTA's growth grade?
Strata Critical Medical, Inc. (SRTA) earns a growth grade of B, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SRTA's profitability grade?
Strata Critical Medical, Inc. (SRTA) earns a profitability grade of C+, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SRTA's financial strength grade?
Strata Critical Medical, Inc. (SRTA) earns a financial strength grade of A-, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for SRTA?
The average analyst price target for Strata Critical Medical, Inc. (SRTA) is $7.25 from 6 analysts, which is +37.6% versus the recent price of $5.27.
What is SRTA's Piotroski score?
Strata Critical Medical, Inc. (SRTA) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.